Basic Information
RNALocate ID: | RLID:01002666 |
RNA Symbol: | hsa-miR-501-3p |
Localization: | Mitochondrion |
RNA Information
RNA Name: | hsa-miR-501-3p |
RNA ID: | miRBase:MIMAT0004774 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 27396686 |
Tissue/Cell Line: | Myotube |
Method: | qRT-PCR |
Description: | Interestingly, miRNA loaded AGO2 and AGO3 proteins has been recently found in mitochondria [19] (Fig. 2), however, the main AGO binding partner-GW182- was absent [185], indicating that the common cytoplasmic RNA-silencing machinery does not operate in mitochondria. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002667 | Mitochondrion | Skeletal muscle cells | 27563705 |
RLID:01002668 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002669 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11003985 | Exosome | Primary dendritic cells | 21505438 |
RLID:11003986 | Exosome | Plasma | 23663360 |
RLID:11003987 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11003988 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000206 | Exosome | Blood | |
RLID-D:11000686 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-501-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-55465 |
MNDR | hsa-miR-501-3p | Ovarian clear cell carcinoma | MNDR-E-MI-55466 |
MNDR | hsa-miR-501-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-55467 |
MNDR | hsa-miR-501-3p | Lymphoma | MNDR-E-MI-55468 |
MNDR | hsa-miR-501-3p | Prostate cancer | MNDR-E-MI-55469 |
MNDR | hsa-miR-501-3p | Alzheimer disease | MNDR-E-MI-55470 |
MNDR | hsa-miR-501-3p | Leukemia | MNDR-E-MI-55471 |
MNDR | hsa-miR-501-3p | Cardiovascular disease | MNDR-E-MI-55472 |
MNDR | hsa-miR-501-3p | Lung cancer | MNDR-E-MI-55473 |
MNDR | hsa-miR-501-3p | Parkinson disease | MNDR-E-MI-55474 |
MNDR | hsa-miR-501-3p | Breast cancer | MNDR-E-MI-55475 |
MNDR | hsa-miR-501-3p | Pancreatic cancer | MNDR-E-MI-55476 |
MNDR | hsa-miR-501-3p | Rectum adenocarcinoma | MNDR-E-MI-55477 |
MNDR | hsa-miR-501-3p | Colon adenocarcinoma | MNDR-E-MI-55478 |
MNDR | hsa-miR-501-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-55479 |
MNDR | hsa-miR-501-3p | Familial ovarian cancer | MNDR-E-MI-55480 |
MNDR | hsa-miR-501-3p | Prostate adenocarcinoma | MNDR-E-MI-55481 |
MNDR | hsa-miR-501-3p | Glioblastoma | MNDR-E-MI-55482 |
MNDR | hsa-miR-501-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-55483 |
MNDR | hsa-miR-501-3p | Osteosarcoma | MNDR-E-MI-55484 |
MNDR | hsa-miR-501-3p | Gastric adenocarcinoma | MNDR-E-MI-55485 |
MNDR | hsa-miR-501-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-55486 |
MNDR | hsa-miR-501-3p | Lung adenocarcinoma | MNDR-E-MI-55487 |
MNDR | hsa-miR-501-3p | Thyroid carcinoma | MNDR-E-MI-55488 |
MNDR | hsa-miR-501-3p | Ovarian carcinoma | MNDR-E-MI-55489 |
MNDR | hsa-miR-501-3p | Pancreatic adenocarcinoma | MNDR-E-MI-55490 |
MNDR | hsa-miR-501-3p | Carcinoma renal cell | MNDR-E-MI-55491 |
MNDR | hsa-miR-501-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-55492 |
MNDR | hsa-miR-501-3p | Renal clear cell carcinoma | MNDR-E-MI-55493 |
MNDR | hsa-miR-501-3p | Cholangiocarcinoma | MNDR-E-MI-55494 |
MNDR | hsa-miR-501-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-55495 |
MNDR | hsa-miR-501-3p | Hepatocellular carcinoma | MNDR-E-MI-55496 |
MNDR | hsa-miR-501-3p | Familiar ovarian carcinoma | MNDR-E-MI-55497 |
MNDR | hsa-miR-501-3p | B-cell lymphoma | MNDR-E-MI-55498 |
MNDR | hsa-miR-501-3p | Rheumatoid arthritis | MNDR-E-MI-55499 |
MNDR | hsa-miR-501-3p | Malignant pleural mesothelioma | MNDR-E-MI-55500 |
MNDR | hsa-miR-501-3p | Hodgkin lymphoma | MNDR-E-MI-55501 |
MNDR | hsa-miR-501-3p | Neuromyelitis optica | MNDR-E-MI-55502 |
MNDR | hsa-miR-501-3p | Skin cutaneous melanoma | MNDR-E-MI-55503 |
MNDR | hsa-miR-501-3p | Skin melanoma | MNDR-E-MI-55504 |
MNDR | hsa-miR-501-3p | Colorectal cancer | MNDR-E-MI-55505 |
MNDR | hsa-miR-501-3p | Nasopharynx carcinoma | MNDR-E-MI-55506 |
MNDR | hsa-miR-501-3p | Nasopharyngeal cancer | MNDR-E-MI-55507 |
MNDR | hsa-miR-501-3p | Epstein-barr virus infections | MNDR-E-MI-55508 |
MNDR | hsa-miR-501-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-55509 |
TOP